197 related articles for article (PubMed ID: 10690381)
1. Recurrent squamous-cell carcinoma of the head and neck: overview of current therapy and future prospects.
Ganly I; Kaye SB
Ann Oncol; 2000 Jan; 11(1):11-6. PubMed ID: 10690381
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for head and neck cancers.
Lamont JP; Kuhn JA; Nemunaitis JJ; McCarty TM
Oncology (Williston Park); 2001 Mar; 15(3):303-8; discussion 311-4. PubMed ID: 11301829
[TBL] [Abstract][Full Text] [Related]
3. Current role of gene therapy in head and neck cancer.
Ganly I; Soutar DS; Kaye SB
Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
Kramer NM; Horwitz EM; Cheng J; Ridge JA; Feigenberg SJ; Cohen RB; Nicolaou N; Sherman EJ; Babb JS; Damsker JA; Langer CJ
Head Neck; 2005 May; 27(5):406-14. PubMed ID: 15719391
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Łasińska I; Kolenda T; Teresiak A; Lamperska KM; Galus Ł; Mackiewicz J
Anticancer Agents Med Chem; 2019; 19(3):290-303. PubMed ID: 30198439
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for Head and Neck Cancer.
Sim F; Leidner R; Bell RB
Oral Maxillofac Surg Clin North Am; 2019 Feb; 31(1):85-100. PubMed ID: 30449528
[TBL] [Abstract][Full Text] [Related]
8. Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma.
Deeken JF; Newkirk K; Harter KW; Marshall MB; Banovac F; Johnson L; Wang H; Wang Y; Zhuang T; Jay AK; Berkowitz F; Esposito G; Kallakury B; Davidson B
Head Neck; 2015 May; 37(5):630-5. PubMed ID: 24616038
[TBL] [Abstract][Full Text] [Related]
9. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
[TBL] [Abstract][Full Text] [Related]
10. Decision making in the management of recurrent head and neck cancer.
Ho AS; Kraus DH; Ganly I; Lee NY; Shah JP; Morris LG
Head Neck; 2014 Jan; 36(1):144-51. PubMed ID: 23471843
[TBL] [Abstract][Full Text] [Related]
11. [Ⅰ. Photo-Immunotherapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck].
Sano D; Oridate N
Gan To Kagaku Ryoho; 2023 Jul; 50(7):775-780. PubMed ID: 37496220
[No Abstract] [Full Text] [Related]
12. [Treatment for recurrent head and neck carcinomas].
Tsukuda M
Gan To Kagaku Ryoho; 1998 Feb; 25(3):303-8. PubMed ID: 9492820
[TBL] [Abstract][Full Text] [Related]
13. New therapies for locoregionally advanced and locoregionally recurrent head and neck cancer.
Wenig BL
Cancer Treat Res; 2003; 114():315-30. PubMed ID: 12619548
[No Abstract] [Full Text] [Related]
14. Locoregional recurrence of an HPV-positive squamous cell carcinoma of the head and neck.
Bowles DW; Reddy K; Wine T; Ree A; Raben D; Chen C; Jimeno A
Oncology (Williston Park); 2011 Oct; 25(11):1042-8. PubMed ID: 22106555
[No Abstract] [Full Text] [Related]
15. A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).
Lamont JP; Nemunaitis J; Kuhn JA; Landers SA; McCarty TM
Ann Surg Oncol; 2000 Sep; 7(8):588-92. PubMed ID: 11005557
[TBL] [Abstract][Full Text] [Related]
16. Managing Recurrent Metastatic Head and Neck Cancer.
Shaikh H; Karivedu V; Wise-Draper TM
Hematol Oncol Clin North Am; 2021 Oct; 35(5):1009-1020. PubMed ID: 34226077
[TBL] [Abstract][Full Text] [Related]
17. Evolving Role of Immunotherapy in Recurrent Metastatic Head and Neck Cancer.
Le X; Ferrarotto R; Wise-Draper T; Gillison M
J Natl Compr Canc Netw; 2020 Jul; 18(7):899-906. PubMed ID: 32634775
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: feasibility and first efficacy results.
Balermpas P; Keller C; Hambek M; Wagenblast J; Seitz O; Rödel C; Weiss C
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e377-83. PubMed ID: 22414284
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary experience in salvage treatment for advanced recurrent cancers of the head and neck].
Jiang PJ; Xu ZG
Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):58-60. PubMed ID: 1889340
[TBL] [Abstract][Full Text] [Related]
20. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.
Mody MD; Gill HS; Saba NF
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):898-905. PubMed ID: 27389786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
